Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 8.60M | $ 8.61M | $ 9.91M | $ 12.32M | $ 6.42M |
Total Assets | $ 2.70B | $ 2.67B | $ 2.25B | $ 1.84B | $ 1.63B |
Total Debt | $ 496.33M | $ 438.66M | $ 427.60M | $ 353.37M | $ 313.02M |
Net Debt | $ 487.73M | $ 430.05M | $ 417.69M | $ 341.04M | $ 306.60M |
Total Liabilities | $ 543.73M | $ 486.00M | $ 473.20M | $ 388.40M | $ 351.49M |
Stockholders Equity | $ 2.15B | $ 2.18B | $ 1.78B | $ 1.45B | $ 1.28B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |